Actin dynamics |
Arp2/3, ERK/MAPK, G-actin, MAL/MRTF, CDC14A, LUZP1, E-cadherin, α-catenin, β-catenin, F-actin, Vinculin, myosin Va |
Stabilizing actin filament networks to control actin dynamics |
(7, 12, 20–24, 26) |
Cell adhesion and metastasis |
PINCH-1, PDGF, paxillin, Rab40b-Cullin5, EGF, EPK signaling pathway, p53, DNp73, IGF1R-AKT/STAT3 signaling pathway |
Regulation of adherens junctions and initiation of the invasion-metastasis cascade |
(29–35) |
EMT |
EGF, DNp73, E-cadherin, β-catenin, Arp2/3, Slug, PI3K-AKT and JAK-STAT signaling pathway |
Bidirectional regulation of the epithelial-to-mesenchymal transition |
(32, 35, 38–45) |
Epithelial defense against cancer |
Cav-1, Myosin II, PKA, Rab5, paxillin |
Promotion of apical extrusion in transformed cells |
(21, 49–51) |
Endothelial dynamics |
VE-cadherin, α-catenin, β-catenin, ARP2/3, cLP, JAIL |
Mediating the formation and maintenance of endothelial cell adherens junctions and integrity |
(54–58) |
Angiogenesis |
ERK, miR-93-5p |
Promotion of new angiogenesis during tumor development |
(59, 60) |
Inflammatory reaction |
MiR-29a-3p, miR-29b-3p, miR-155-5p |
Stimulation of inflammatory cytokines, leading to endothelial barrier dysfunction |
(63) |
Cell division |
Arv1, supervillin, Myosin II, septin 2, small GTPases, RhoA |
Cooperating to modulate actin and microtubule motor functions, drive the contraction of the cleavage furrow and maintain proper cell division |
(66–68) |
Membrane dynamics |
Actin, β-catenin, p120, the naïve pluripotency transcription factors |
Pluripotency control of membrane dynamics and cellular metabolism |
(71) |
Lipid metabolism |
NPC1L1 |
Regulation of cholesterol transport and promotion of effective cholesterol absorption by the intestines |
(75–77) |